Therapeutic vaccination with Tat restores immune homeostasis, promotes proviral DNA decay and induces cross clade neutralizing antibodies in patients on HAART: Results from phase II clinical trials in Italy and South Afr
cell number and restored CD4+ and CD8+ central memory subsets, independently from CD4 nadir and particularly in the most immunocompromised patients. Remarkably, proviral DNA load progressively decreased in vaccines…

